A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation
- 30 September 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 124 (3) , 645-650
- https://doi.org/10.1016/0002-8703(92)90272-w
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Prophylactic treatment after electroconversion of atrial fibrillationClinical Cardiology, 1990
- Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.Heart, 1990
- Clinical approach to paroxysmal atrial fibrillationClinical Cardiology, 1990
- Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.Circulation, 1989
- Usefulness of propafenone for recurrent paroxysmal atrial fibrillationThe American Journal of Cardiology, 1989
- Oral flecainide for prophylaxis of paroxysmal atrial fibrillationThe American Journal of Cardiology, 1988
- Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapyJournal of the American College of Cardiology, 1985
- Atrial Fibrillation RevisitedNew England Journal of Medicine, 1982
- Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversionClinical Pharmacology & Therapeutics, 1974